Among the transcription factors which play a role in prostate cancer neuroendocrine transdifferentiation, are the transcription factors able to produce induced pluripotent stem cells: the Yamanaka pluripotency factors OCT4, SOX2, KLF4 and MYC, along with NANOG [128]. This evidence concerns the gene SOX2 and prostate carcinoma.